SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001685071-18-000010
Filing Date
2018-11-08
Accepted
2018-11-08 16:31:05
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dovaq3201810-q.htm 10-Q 661455
2 EXHIBIT 10.2 dovaq32018ex102co-promotio.htm EX-10.2 470542
3 EXHIBIT 10.3 dovaq32018ex103amendedtsa.htm EX-10.3 357878
4 EXHIBIT 31.1 dovaq32018ex311.htm EX-31.1 12043
5 EXHIBIT 31.2 dovaq32018ex312.htm EX-31.2 12053
6 EXHIBIT 32.1 dovaq32018ex321.htm EX-32.1 8962
  Complete submission text file 0001685071-18-000010.txt   4455510

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dova-20180930.xml EX-101.INS 498138
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dova-20180930.xsd EX-101.SCH 40810
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dova-20180930_cal.xml EX-101.CAL 50211
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dova-20180930_def.xml EX-101.DEF 198175
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dova-20180930_lab.xml EX-101.LAB 509786
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dova-20180930_pre.xml EX-101.PRE 293521
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38135 | Film No.: 181170116
SIC: 2834 Pharmaceutical Preparations